-+ 0.00%
-+ 0.00%
-+ 0.00%

Century Therapeutics Q1 EPS $(0.11) Beats $(0.17) Estimate

Benzinga·05/13/2026 12:20:37
Listen to the news
Century Therapeutics (NASDAQ:IPSC) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.17) by 31.25 percent. This is a 112.36 percent decrease over earnings of $0.89 per share from the same period last year.